Skip to main content
Fig. 4 | Clinical Epigenetics

Fig. 4

From: Low levels of circulating methylated IRX3 are related to worse outcome after transcatheter aortic valve implantation in patients with severe aortic stenosis

Fig. 4

Survival analysis depending on circulating IRX3 promoter methylation level. Kaplan–Meier curves showing all-cause (A) and cardiac (B) mortality for the first 600 days after TAVI in patients with circulating IRX3 promoter methylation below (green) and above (red) the median. A Patients with promoter methylation above the median show a better survival and outcome after TAVI as compared to those with promoter methylation below the median for all-cause mortality. B Both groups of promoter methylation above and promoter methylation below the median show no significant difference for cardiac mortality after TAVI

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us